Avior Wealth Management LLC Sells 1,893 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Avior Wealth Management LLC lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 36.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,244 shares of the pharmacy operator’s stock after selling 1,893 shares during the quarter. Avior Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $85,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Milestone Investment Advisors LLC bought a new stake in Walgreens Boots Alliance during the 1st quarter valued at approximately $31,000. Penserra Capital Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $34,000. Highlander Capital Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC increased its stake in Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in Walgreens Boots Alliance by 308.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 845 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Insider Activity at Walgreens Boots Alliance

In related news, Director Valerie B. Jarrett purchased 4,456 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares in the company, valued at $99,992.64. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Valerie B. Jarrett purchased 4,456 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares in the company, valued at $99,992.64. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 13,456 shares of company stock valued at $270,423. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Trading Up 3.7 %

Shares of Walgreens Boots Alliance stock opened at $18.24 on Friday. The business has a 50 day simple moving average of $20.42 and a two-hundred day simple moving average of $21.92. Walgreens Boots Alliance, Inc. has a 12 month low of $17.51 and a 12 month high of $36.14. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter last year, the firm earned $1.16 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. SVB Leerink dropped their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a report on Monday, March 18th. Bank of America lowered their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. HSBC reiterated a “reduce” rating and set a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Truist Financial reiterated a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Finally, TD Cowen lowered their price target on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.